Real-World Safety and Effectiveness of Up to 12 Months of Tralokinumab Treatment in Adults With Atopic Dermatitis Who Discontinued Dupilumab Due to Conjunctivitis. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 Apr. 30];10(2):s729. Available from: https://skin.dermsquared.com/skin/article/view/4040